Koers Peloton Therapeutics, Inc.
Aandelen
PLTX
US70614L1044
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Naseem Zojwalla
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Corporate Officer/Principal | - | - | |
Peter Stenge
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Helen Kim
BRD | Director/Board Member | 61 | 01-11-17 |
Brett A. Ringle
BRD | Director/Board Member | 73 | 01-01-11 |
David Chang
BRD | Director/Board Member | 64 | 01-02-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,21% | 115 mld. | |
+12,94% | 107 mld. | |
-13,61% | 22,31 mld. | |
-3,99% | 21,6 mld. | |
-5,76% | 18,23 mld. | |
-39,93% | 17,62 mld. | |
+7,30% | 14,26 mld. | |
+33,58% | 12,37 mld. | |
-28,00% | 8,28 mld. |